Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Metastatic Carcinoma to the Liver”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT04194801
What this trial is testing

A Phase Ib/II Study of Fisogatinib(BLU-554) in Subjects With Hepatocellular Carcinoma

Who this might be right for
Hepatocellular Carcinoma
CStone Pharmaceuticals 26
Not applicableWithdrawnNCT05641922
What this trial is testing

Safety and Effectiveness of BioTraceIO 360 for Planning, Monitoring and Assessment of Liver Tissue Ablation Procedures (PANORAMA2)

Who this might be right for
Hepatocellular CarcinomaMetastatic Liver Cancer
Techsomed Medical Technologies LTD
Testing effectiveness (Phase 2)Study completedNCT03366155
What this trial is testing

Hepatic Artery Infusion Pump Chemotherapy With Floxuridine and Dexamethasone in Combination With Systemic Chemotherapy for Patients With Colorectal Cancer Metastatic to the Liver

Who this might be right for
Colorectal CancerLiver MetastasesColorectal Adenocarcinoma+2 more
National Cancer Institute (NCI) 24
Testing effectiveness (Phase 2)Active Not RecruitingNCT05822752
What this trial is testing

Study to Evaluate Adverse Events, and Change in Disease Activity, When Intravenously (IV) Infused With Livmoniplimab in Combination With IV Infused Budigalimab in Adult Participants With Hepatocellular Carcinoma (HCC)

Who this might be right for
Hepatocellular Carcinoma
AbbVie 130
Early research (Phase 1)Ended earlyNCT00623077
What this trial is testing

MT2004-30: Tomotherapy for Solid Tumors

Who this might be right for
Brain and Central Nervous System TumorsKidney CancerLiver Cancer+2 more
Masonic Cancer Center, University of Minnesota 23
Early research (Phase 1)Ended earlyNCT03998033
What this trial is testing

Study of ET140202 T Cells in Adults With Advanced Hepatocellular Carcinoma

Who this might be right for
Hepatocellular CarcinomaLiver CancerLiver Neoplasm+1 more
Eureka Therapeutics Inc. 2
Testing effectiveness (Phase 2)Ended earlyNCT05070247
What this trial is testing

TAK-500 With or Without Pembrolizumab in Adults With Select Locally Advanced or Metastatic Solid Tumors

Who this might be right for
Pancreatic CancerHepatocellular CancerMesothelioma+7 more
Takeda 61
Testing effectiveness (Phase 2)Ended earlyNCT03316222
What this trial is testing

Study of GNS561 in Patients With Liver Cancer

Who this might be right for
Hepatocellular CarcinomaCholangiocarcinoma, Intrahepatic
Genoscience Pharma 50
Testing effectiveness (Phase 2)Study completedNCT04401800
What this trial is testing

Preliminary Antitumor Activity, Safety and Tolerability of Tislelizumab in Combination With Lenvatinib for Hepatocellular Carcinoma

Who this might be right for
Hepatocellular CarcinomaUnresectable Hepatocellular CarcinomaMetastatic Hepatocellular Carcinoma
BeiGene 64
Early research (Phase 1)Ended earlyNCT03818165
What this trial is testing

Phase 1b Study of CAR2Anti-CEA CAR-T Cell Hepatic Infusions for Pancreatic Carcinoma Patients With CEA+ Liver Metastases

Who this might be right for
Metastatic Pancreatic Carcinoma
Sorrento Therapeutics, Inc. 2
Testing effectiveness (Phase 2)Looking for participantsNCT05914116
What this trial is testing

A Phase 1/2a Study of DB-1311/BNT324 in Advanced/Metastatic Solid Tumors

Who this might be right for
Advanced Solid Tumors
DualityBio Inc. 862
Not applicableLooking for participantsNCT05443087
What this trial is testing

TARGETed Therapy Drug MONITOring in DIGestive Oncology

Who this might be right for
Digestive CancerMetastatic Colorectal CancerHepatocellular Carcinoma+2 more
UNICANCER 330
Early research (Phase 1)Not Yet RecruitingNCT07558200
What this trial is testing

Phase Ia/Ib Study of FXB0871 Monotherapy in Locally Advanced/Metastatic Solid Tumors

Who this might be right for
Solid TumorsNon-Small Cell Lung CancerHepatocellular Carcinoma
Shanghai Fosun Pharmaceutical Industrial Development Co. Ltd. 138
Testing effectiveness (Phase 2)Looking for participantsNCT07341737
What this trial is testing

SL-28 for Advanced Solid Tumours

Who this might be right for
Head & Neck CancerPancreas CarcinomaPancreas Cancer, Metastatic+15 more
Second Life Therapeutics 60
Not applicableStudy completedNCT00132704
What this trial is testing

An Analysis of the Response of Human Tumor Microvascular Endothelium to Ionizing Radiation

Who this might be right for
Ovarian NeoplasmsColorectal NeoplasmsMelanoma+2 more
Memorial Sloan Kettering Cancer Center 149
Early research (Phase 1)Study completedNCT04430842
What this trial is testing

Dose Escalation Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of QBS10072S

Who this might be right for
AstrocytomaBrain CancerBrain Metastases+20 more
Quadriga Biosciences, Inc. 15
Testing effectiveness (Phase 2)Active Not RecruitingNCT06084884
What this trial is testing

A Phase I/II Study to Evaluate AZD5851 in GPC3+ Advanced/Recurrent Hepatocellular Carcinoma

Who this might be right for
Hepatocellular Carcinoma
AstraZeneca 94
Early research (Phase 1)Looking for participantsNCT06910657
What this trial is testing

IDOV-Immune for Advanced Solid Tumors

Who this might be right for
Colorectal CancerPancreatic CancerMelanoma+13 more
ViroMissile, Inc. 78
Early research (Phase 1)Study completedNCT00003427
What this trial is testing

Oxaliplatin Plus Irinotecan in Treating Patients With Metastatic Gastrointestinal Cancer

Who this might be right for
Anal CancerColorectal CancerEsophageal Cancer+7 more
Memorial Sloan Kettering Cancer Center 36
Large-scale testing (Phase 3)Looking for participantsNCT07490262
What this trial is testing

Evaluate the Efficacy and Safety of IBI310 and Sintilimab Combination Therapy in Patients With Hepatocellular Carcinoma as First-line Treatment.

Who this might be right for
Hepatocellular Carcinoma (HCC)
Innovent Biopharmaceutical Technology (Hangzhou) Co., LTD. 680
Next Page